Home / Search / Taro Pharmaceutical Articles

Israeli drug firm Taro Pharmaceutical Industries today asked Sun Pharma to pay USD 15 per share for merger, while rejecting the USD-9.5 per share offer proposed by the Mumbai-based firm.